Obstructive sleep apnea is common in people with cognitive impairment, researchers report. The severity of obstructive sleep apnea correlated with the degree of cognitive impairment.
Gait variability in older adults could be a predictor of cognitive decline and Alzheimer's disease. Researchers found higher gait variability was associated with lower cognitive performance and an accurate predictor of Alzheimer's disease.
Specific patterns of frontal brainwaves during everyday memory tasks help researchers to predict a patient's risk for developing mild cognitive impairment within five years.
A simple vision test can predict whether a person with Parkinson's disease will develop cognitive decline or dementia within 18 months.
A new study reveals the impact of diet on cognitive health as we age. Researchers found cheese consumption had neuroprotective effects against cognitive decline. Daily moderate consumption of red wine was associated with improvements in cognitive function.
Higher baseline levels of N-terminal fragment of tau in the blood of healthy subjects was associated with an increased risk of developing cognitive deficits and Alzheimer's disease later in life.
Short-term exposure to an experimental drug reverses age-related memory decline and cognitive deficits in mice. The drug, ISRIB, has previously shown beneficial effects in treating memory loss associated with TBI and other neurological disorders.
People who reported chronic insomnia or sleep duration of fewer than six hours were twice as likely to experience cognitive impairment compared to those who experienced good sleeping patterns. The association was stronger for those with coexisting cardiometabolic conditions.
Older people who have higher levels of neuroticism are more likely to have worse cognitive function than those with other personality traits. Researchers say personality traits may be related to how well people can maintain their cognitive function, despite developing neuropathology associated with aging and dementia.
Metformin, a drug commonly used to treat diabetes, slows cognitive decline and reduces dementia risk in older people with diabetes.
A genetic variation that alters the metabolism of glutathione may be responsible for cognitive decline in people who do not have other associated biomarkers, a new study reports.